Showing results (21-30 of 90) with videos related to

Sort By:
Pageof 9
Analytical Chemistry|July 22, 2021
De Novo Sequencing of Antibody Light Chain Proteoforms from Patients with Multiple MyelomaMathieu Dupré, Magalie Duchateau, Rebecca Sternke-Hoffmann, et al.
Journal of Virological Methods|May 17, 2005
Quantitative real-time PCR for titration of infectious recombinant AAV-2 particlesUlrich-Peter Rohr, Florian Heyd, Judith Neukirchen, et al.
European Biophysics Journal : EBJ|August 5, 2025
Tracking reduction-induced molecular changes in pathological free light chains by SV-AUCFlorian T Tucholski, Rebecca Sternke-Hoffmann, Thomas Pauly, et al.
Clinical Endocrinology|August 5, 2006
Dendritic cells as potential adjuvant for immunotherapy in adrenocortical carcinomaClaudia Papewalis, Martin Fassnacht, Holger S Willenberg, et al.
British Journal of Haematology|April 14, 2006
Delayed diagnosis and complications of Fanconi anaemia at advanced age--a paradigmKirsten Huck, Helmut Hanenberg, Sonja Gudowius, et al.
Journal of Translational Medicine|September 27, 2007
Monocyte derived dendritic cells generated by IFN-alpha acquire mature dendritic and natural killer cell properties as shown by gene expression analysisMark Korthals, Nancy Safaian, Ralf Kronenwett, et al.
Hematological Oncology|May 2, 2008
Therapy adapted to molecular response in patients with chronic myelogenous leukaemia in first chronic phase: results of the Duesseldorf studyFrank Neumann, Judith Markett, Roland Fenk, et al.
Haematologica|May 12, 2004
Levels of minimal residual disease detected by quantitative molecular monitoring herald relapse in patients with multiple myelomaRoland Fenk, Muharrem Ak, Guido Kobbe, et al.
Transfusion|January 31, 2006
A single dose of 6 or 12 mg of pegfilgrastim for peripheral blood progenitor cell mobilization results in similar yields of CD34+ progenitors in patients with multiple myelomaIngmar Bruns, Ulrich Steidl, Ralf Kronenwett, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|October 4, 2011
Upfront allogeneic blood stem cell transplantation for patients with high-risk myelodysplastic syndrome or secondary acute myeloid leukemia using a FLAMSA-based high-dose sequential conditioning regimenChristian Saure, Thomas Schroeder, Fabian Zohren, et al.
Pageof 9